Search results for “Cellular composition” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 736 patents, we discovered top 220 key players by total patent application. Oncolytics Biotech, Inc., Anthrogenesis Corp., Mesoblast International SARL are dominant in this area. They take 11.68% of the total patent filing.
Alberta, Canada
Patent: 40
New Jersey, United States
Patent: 24
Switzerland
Patent: 22
Washington, United States
Patent: 17
United States
Patent: 14
California, United States
Patent: 13
California, United States
Patent: 11
California, United States
Patent: 11
Massachusetts, United States
Patent: 9
New Jersey, United States
Patent: 8
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 44 patents, we discovered top 16 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, LifeScore Ltd., BostonGene Corp. are active in this area.
STARTUP
France
Patent: 11
STARTUP
United Kingdom
Patent: 7
STARTUP
Massachusetts, United States
Patent: 6
Illinois, United States
Patent: 4
STARTUP
Technologies Morphocell, Inc.
Quebec, Canada
Patent: 4
STARTUP
California, United States
Patent: 2
Daman and Diu, India
Patent: 1
STARTUP
Massachusetts, United States
Patent: 1
STARTUP
Vauban Technologies Ltd.
United Kingdom
Patent: 1
STARTUP
Tokyo-to, Japan
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 241 patents applied in the last 5 years. We discover 88 most active companies in this area. The fast-growing Mesoblast International SARL, Juno Therapeutics, Inc., Medeor Therapeutics, Inc. take 20.75% of patent filing during this period.
Switzerland
Patent: 22
Washington, United States
Patent: 15
California, United States
Patent: 13
New York, United States
Patent: 7
STARTUP
Massachusetts, United States
Patent: 6
California, United States
Patent: 6
South Korea
Patent: 5
Saitama-ken, Japan
Patent: 5
Shanghai Shi, China
Patent: 5
Suzhou Genxi Biological Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 5
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 241 patents in last 5 years, we discover 56 new entrants. Mesoblast International SARL, Medeor Therapeutics, Inc., Enochian Biopharma, Inc. are the most active new entrants in this area.
Switzerland
Patent: 22
California, United States
Patent: 13
New York, United States
Patent: 7
STARTUP
Massachusetts, United States
Patent: 6
California, United States
Patent: 6
Saitama-ken, Japan
Patent: 5
Shanghai Shi, China
Patent: 5
Suzhou Genxi Biological Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 5
Bayern, Germany
Patent: 5
STARTUP
Technologies Morphocell, Inc.
Quebec, Canada
Patent: 4
Research Institutions
Order by:
Innovation Intensity
With the analysis among 245 patents, we discovered top 58 universities and scientific research institutions by total patent application. Emory University, Vrije Universiteit Brussel, University of Chile are dominant in this area. They take 20.41% of the total patent filing.
Georgia, United States
Patent: 13
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 10
Chile
Patent: 9
Tokyo-to, Japan
Patent: 8
Belgium
Patent: 8
Kyoto-fu, Japan
Patent: 6
Institut Gustave Roussy EURL
France
Patent: 5
United States
Patent: 5
New York, United States
Patent: 5
Arizona, United States
Patent: 4
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: